Kayne Anderson Rudnick Investment Management
GH icon

Kayne Anderson Rudnick Investment Management’s Guardant Health GH Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5
Closed -$144 – 1001
2024
Q2 		$144 Buy
+5
New +$116 ﹤0.01% 982
2021
Q1 		– Sell
-3
Closed – – 625
2020
Q4 		$0 Buy
+3
New +$345 ﹤0.01% 702

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's GH Position: Q3 2024 in Review

Kayne Anderson Rudnick Investment Management sold out of Guardant Health (GH) in Q3 2024, closing a stake of 5 shares — an estimated $144 sold.

Kayne Anderson Rudnick Investment Management first reported a position in GH in Q4 2020 and held it in 2 quarters. The position peaked at $144 in Q2 2024. 271 funds tracked by Wall St. Rank hold GH as of Q3 2024.

  • Kayne Anderson Rudnick Investment Management reported no remaining Guardant Health position as of Q3 2024 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 5 Guardant Health shares in Q3 2024, an estimated $144.
  • Kayne Anderson Rudnick Investment Management first reported a position in Guardant Health in Q4 2020 and held it in 2 quarters.
  • Kayne Anderson Rudnick Investment Management's Guardant Health position peaked at $144 in Q2 2024.
  • 271 funds tracked by Wall St. Rank held Guardant Health as of Q3 2024.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q3 2024, filed 13 Nov 2024.